List of Tables
Table 1. Global Ophiopogonin D Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
Table 2. Global Ophiopogonin D Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
Table 3. Global Ophiopogonin D Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 4. Global Ophiopogonin D Revenue by Region (2020-2025) & (US$ Million)
Table 5. Global Ophiopogonin D Revenue by Region (2026-2031) & (US$ Million)
Table 6. Global Ophiopogonin D Sales Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (kg)
Table 7. Global Ophiopogonin D Sales by Region (2020-2025) & (kg)
Table 8. Global Ophiopogonin D Sales by Region (2026-2031) & (kg)
Table 9. Emerging Market Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 10. Global Ophiopogonin D Production Growth Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (kg)
Table 11. Global Ophiopogonin D Production by Region (2020-2025) & (kg)
Table 12. Global Ophiopogonin D Production by Region (2026-2031) & (kg)
Table 13. Global Ophiopogonin D Sales by Manufacturers (2020-2025) & (kg)
Table 14. Global Ophiopogonin D Sales Share by Manufacturers (2020-2025)
Table 15. Global Ophiopogonin D Revenue by Manufacturers (2020-2025) & (US$ Million)
Table 16. Global Ophiopogonin D Revenue Market Share by Manufacturers (2020-2025)
Table 17. Global Key Manufacturers’Ranking Shift (2023 vs. 2024) (Based on Revenue)
Table 18. Global Ophiopogonin D by Manufacturer Tier (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Ophiopogonin D as of 2024)
Table 19. Global Ophiopogonin D Average Gross Margin (%) by Manufacturer (2020 VS 2024)
Table 20. Global Ophiopogonin D Average Selling Price (ASP) by Manufacturers (2020-2025) & (US$/g)
Table 21. Key Manufacturers Ophiopogonin D Manufacturing Base and Headquarters
Table 22. Global Ophiopogonin D Market Concentration Ratio (CR5 and HHI)
Table 23. Key Market Entrant/Exit (2020-2024) – Drivers & Impact Analysis
Table 24. Key Mergers & Acquisitions, Expansion Plans, R&D Investment
Table 25. Global Ophiopogonin D Sales by Type (2020-2025) & (kg)
Table 26. Global Ophiopogonin D Sales by Type (2026-2031) & (kg)
Table 27. Global Ophiopogonin D Revenue by Type (2020-2025) & (US$ Million)
Table 28. Global Ophiopogonin D Revenue by Type (2026-2031) & (US$ Million)
Table 29. Global Ophiopogonin D ASP by Type (2020-2031) & (US$/g)
Table 30. Technical Specifications by Key Product Type
Table 31. Global Ophiopogonin D Sales by Application (2020-2025) & (kg)
Table 32. Global Ophiopogonin D Sales by Application (2026-2031) & (kg)
Table 33. Ophiopogonin D High-Growth Sectors Demand CAGR (2024-2031)
Table 34. Global Ophiopogonin D Revenue by Application (2020-2025) & (US$ Million)
Table 35. Global Ophiopogonin D Revenue by Application (2026-2031) & (US$ Million)
Table 36. Global Ophiopogonin D ASP by Application (2020-2031) & (US$/g)
Table 37. Top Customers by Region
Table 38. Top Customers by Application
Table 39. North America Ophiopogonin D Growth Accelerators and Market Barriers
Table 40. North America Ophiopogonin D Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 41. North America Ophiopogonin D Sales (kg) by Country (2020 VS 2024 VS 2031)
Table 42. Europe Ophiopogonin D Growth Accelerators and Market Barriers
Table 43. Europe Ophiopogonin D Revenue Grow Rate (CAGR) by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 44. Europe Ophiopogonin D Sales (kg) by Country (2020 VS 2024 VS 2031)
Table 45. Asia-Pacific Ophiopogonin D Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 46. Asia-Pacific Ophiopogonin D Sales (kg) by Country (2020 VS 2024 VS 2031)
Table 47. Asia-Pacific Ophiopogonin D Growth Accelerators and Market Barriers
Table 48. Southeast Asia Ophiopogonin D Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 49. Central and South America Ophiopogonin D Investment Opportunities and Key Challenges
Table 50. Central and South America Ophiopogonin D Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 51. Middle East and Africa Ophiopogonin D Investment Opportunities and Key Challenges
Table 52. Middle East and Africa Ophiopogonin D Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 53. MedChemExpresss Corporation Information
Table 54. MedChemExpresss Description and Major Businesses
Table 55. MedChemExpresss Product Models, Descriptions and Specifications
Table 56. MedChemExpresss Capacity, Sales (kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2020-2025)
Table 57. MedChemExpresss Sales Value Proportion by Product in 2024
Table 58. MedChemExpresss Sales Value Proportion by Application in 2024
Table 59. MedChemExpresss Sales Value Proportion by Geographic Area in 2024
Table 60. MedChemExpresss Ophiopogonin D SWOT Analysis
Table 61. MedChemExpresss Recent Developments
Table 62. Merck Corporation Information
Table 63. Merck Description and Major Businesses
Table 64. Merck Product Models, Descriptions and Specifications
Table 65. Merck Capacity, Sales (kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2020-2025)
Table 66. Merck Sales Value Proportion by Product in 2024
Table 67. Merck Sales Value Proportion by Application in 2024
Table 68. Merck Sales Value Proportion by Geographic Area in 2024
Table 69. Merck Ophiopogonin D SWOT Analysis
Table 70. Merck Recent Developments
Table 71. Targetmol Corporation Information
Table 72. Targetmol Description and Major Businesses
Table 73. Targetmol Product Models, Descriptions and Specifications
Table 74. Targetmol Capacity, Sales (kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2020-2025)
Table 75. Targetmol Sales Value Proportion by Product in 2024
Table 76. Targetmol Sales Value Proportion by Application in 2024
Table 77. Targetmol Sales Value Proportion by Geographic Area in 2024
Table 78. Targetmol Ophiopogonin D SWOT Analysis
Table 79. Targetmol Recent Developments
Table 80. Cayman Chemical Corporation Information
Table 81. Cayman Chemical Description and Major Businesses
Table 82. Cayman Chemical Product Models, Descriptions and Specifications
Table 83. Cayman Chemical Capacity, Sales (kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2020-2025)
Table 84. Cayman Chemical Sales Value Proportion by Product in 2024
Table 85. Cayman Chemical Sales Value Proportion by Application in 2024
Table 86. Cayman Chemical Sales Value Proportion by Geographic Area in 2024
Table 87. Cayman Chemical Ophiopogonin D SWOT Analysis
Table 88. Cayman Chemical Recent Developments
Table 89. Raybiotech Corporation Information
Table 90. Raybiotech Description and Major Businesses
Table 91. Raybiotech Product Models, Descriptions and Specifications
Table 92. Raybiotech Capacity, Sales (kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2020-2025)
Table 93. Raybiotech Sales Value Proportion by Product in 2024
Table 94. Raybiotech Sales Value Proportion by Application in 2024
Table 95. Raybiotech Sales Value Proportion by Geographic Area in 2024
Table 96. Raybiotech Ophiopogonin D SWOT Analysis
Table 97. Raybiotech Recent Developments
Table 98. Biosynth Corporation Information
Table 99. Biosynth Description and Major Businesses
Table 100. Biosynth Product Models, Descriptions and Specifications
Table 101. Biosynth Capacity, Sales (kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2020-2025)
Table 102. Biosynth Recent Developments
Table 103. Chemfaces Corporation Information
Table 104. Chemfaces Description and Major Businesses
Table 105. Chemfaces Product Models, Descriptions and Specifications
Table 106. Chemfaces Capacity, Sales (kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2020-2025)
Table 107. Chemfaces Recent Developments
Table 108. Key Organics Corporation Information
Table 109. Key Organics Description and Major Businesses
Table 110. Key Organics Product Models, Descriptions and Specifications
Table 111. Key Organics Capacity, Sales (kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2020-2025)
Table 112. Key Organics Recent Developments
Table 113. Adooq Bioscience Corporation Information
Table 114. Adooq Bioscience Description and Major Businesses
Table 115. Adooq Bioscience Product Models, Descriptions and Specifications
Table 116. Adooq Bioscience Capacity, Sales (kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2020-2025)
Table 117. Adooq Bioscience Recent Developments
Table 118. Biorbyt Corporation Information
Table 119. Biorbyt Description and Major Businesses
Table 120. Biorbyt Product Models, Descriptions and Specifications
Table 121. Biorbyt Capacity, Sales (kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2020-2025)
Table 122. Biorbyt Recent Developments
Table 123. Yeasen Biotechnology Corporation Information
Table 124. Yeasen Biotechnology Description and Major Businesses
Table 125. Yeasen Biotechnology Product Models, Descriptions and Specifications
Table 126. Yeasen Biotechnology Capacity, Sales (kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2020-2025)
Table 127. Yeasen Biotechnology Recent Developments
Table 128. Meilunbio Corporation Information
Table 129. Meilunbio Description and Major Businesses
Table 130. Meilunbio Product Models, Descriptions and Specifications
Table 131. Meilunbio Capacity, Sales (kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2020-2025)
Table 132. Meilunbio Recent Developments
Table 133. Shanghai Wokai Biotechnology Corporation Information
Table 134. Shanghai Wokai Biotechnology Description and Major Businesses
Table 135. Shanghai Wokai Biotechnology Product Models, Descriptions and Specifications
Table 136. Shanghai Wokai Biotechnology Capacity, Sales (kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2020-2025)
Table 137. Shanghai Wokai Biotechnology Recent Developments
Table 138. Key Raw Materials Distribution
Table 139. Raw Materials Key Suppliers
Table 140. Critical Raw Material Supplier Concentration (2024) & Risk Index
Table 141. Milestones in Production Technology Evolution
Table 142. Distributors List
Table 143. Market Trends and Market Evolution
Table 144. Market Drivers and Opportunities
Table 145. Market Challenges, Risks, and Restraints
Table 146. Research Programs/Design for This Report
Table 147. Key Data Information from Secondary Sources
Table 148. Key Data Information from Primary Sources
List of Figures
Figure 1. Ophiopogonin D Product Picture
Figure 2. Global Ophiopogonin D Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
Figure 3. Purity≥98% Product Picture
Figure 4. Purity ≥95% Product Picture
Figure 5. Others Product Picture
Figure 6. Global Ophiopogonin D Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
Figure 7. Pharmaceutical
Figure 8. Scientific Research
Figure 9. Others
Figure 10. Ophiopogonin D Report Years Considered
Figure 11. Global Ophiopogonin D Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 12. Global Ophiopogonin D Revenue (2020-2031) & (US$ Million)
Figure 13. Global Ophiopogonin D Revenue (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Figure 14. Global Ophiopogonin D Revenue Market Share by Region (2020-2031)
Figure 15. Global Ophiopogonin D Sales (2020-2031) & (kg)
Figure 16. Global Ophiopogonin D Sales (CAGR) by Region (2020-2031) (kg)
Figure 17. Global Ophiopogonin D Sales Market Share by Region (2020-2031)
Figure 18. Global Ophiopogonin D Capacity, Production and Utilization (2020-2031) & (kg)
Figure 19. Global Ophiopogonin D Production Trend by Region (2020-2031) (kg)
Figure 20. Global Ophiopogonin D Production Market Share by Region (2020-2031)
Figure 21. Production Capacity Enablers & Constraints
Figure 22. Ophiopogonin D Production Growth Rate in North America (2020-2031) & (kg)
Figure 23. Ophiopogonin D Production Growth Rate in Europe (2020-2031) & (kg)
Figure 24. Ophiopogonin D Production Growth Rate in China (2020-2031) & (kg)
Figure 25. Ophiopogonin D Production Growth Rate in Japan (2020-2031) & (kg)
Figure 26. Top 5 and Top 10 Manufacturers Ophiopogonin D Sales Volume Market Share in 2024
Figure 27. Global Ophiopogonin D Revenue Market Share Ranking (2024)
Figure 28. Tier Distribution by Revenue Contribution (2020 VS 2024)
Figure 29. Purity≥98% Revenue Market Share by Manufacturer in 2024
Figure 30. Purity ≥95% Revenue Market Share by Manufacturer in 2024
Figure 31. Others Revenue Market Share by Manufacturer in 2024
Figure 32. Type Eight Revenue Market Share by Manufacturer in 2024
Figure 33. Type Nine Revenue Market Share by Manufacturer in 2024
Figure 34. Global Ophiopogonin D Sales Market Share by Type (2020-2031)
Figure 35. Global Ophiopogonin D Revenue Market Share by Type (2020-2031)
Figure 36. Global Ophiopogonin D Sales Market Share by Application (2020-2031)
Figure 37. Global Ophiopogonin D Revenue Market Share by Application (2020-2031)
Figure 38. North America Ophiopogonin D Sales YoY (2020-2031) & (kg)
Figure 39. North America Ophiopogonin D Revenue YoY (2020-2031) & (US$ Million)
Figure 40. North America Top 5 Manufacturers Ophiopogonin D Sales Revenue (US$ Million) in 2024
Figure 41. North America Ophiopogonin D Sales Volume (kg) by Type (2020- 2031)
Figure 42. North America Ophiopogonin D Sales Revenue (US$ Million) by Type (2020 - 2031)
Figure 43. North America Ophiopogonin D Sales Volume (kg) by Application (2020-2031)
Figure 44. North America Ophiopogonin D Sales Revenue (US$ Million) by Application (2020-2031)
Figure 45. US Ophiopogonin D Revenue (2020-2031) & (US$ Million)
Figure 46. Canada Ophiopogonin D Revenue (2020-2031) & (US$ Million)
Figure 47. Mexico Ophiopogonin D Revenue (2020-2031) & (US$ Million)
Figure 48. Europe Ophiopogonin D Sales YoY (2020-2031) & (kg)
Figure 49. Europe Ophiopogonin D Revenue YoY (2020-2031) & (US$ Million)
Figure 50. Europe Top 5 Manufacturers Ophiopogonin D Sales Revenue (US$ Million) in 2024
Figure 51. Europe Ophiopogonin D Sales Volume (kg) by Type (2020-2031)
Figure 52. Europe Ophiopogonin D Sales Revenue (US$ Million) by Type (2020-2031)
Figure 53. Europe Ophiopogonin D Sales Volume (kg) by Application (2020-2031)
Figure 54. Europe Ophiopogonin D Sales Revenue (US$ Million) by Application (2020-2031)
Figure 55. Germany Ophiopogonin D Revenue (2020-2031) & (US$ Million)
Figure 56. France Ophiopogonin D Revenue (2020-2031) & (US$ Million)
Figure 57. U.K. Ophiopogonin D Revenue (2020-2031) & (US$ Million)
Figure 58. Italy Ophiopogonin D Revenue (2020-2031) & (US$ Million)
Figure 59. Russia Ophiopogonin D Revenue (2020-2031) & (US$ Million)
Figure 60. Asia-Pacific Ophiopogonin D Sales YoY (2020-2031) & (kg)
Figure 61. Asia-Pacific Ophiopogonin D Revenue YoY (2020-2031) & (US$ Million)
Figure 62. Asia-Pacific Top 8 Manufacturers Ophiopogonin D Sales Revenue (US$ Million) in 2024
Figure 63. Asia-Pacific Ophiopogonin D Sales Volume (kg) by Type (2020- 2031)
Figure 64. Asia-Pacific Ophiopogonin D Sales Revenue (US$ Million) by Type (2020- 2031)
Figure 65. Asia-Pacific Ophiopogonin D Sales Volume (kg) by Application (2020-2031)
Figure 66. Asia-Pacific Ophiopogonin D Sales Revenue (US$ Million) by Application (2020-2031)
Figure 67. Indonesia Ophiopogonin D Revenue (2020-2031) & (US$ Million)
Figure 68. Japan Ophiopogonin D Revenue (2020-2031) & (US$ Million)
Figure 69. South Korea Ophiopogonin D Revenue (2020-2031) & (US$ Million)
Figure 70. China Taiwan Ophiopogonin D Revenue (2020-2031) & (US$ Million)
Figure 71. India Ophiopogonin D Revenue (2020-2031) & (US$ Million)
Figure 72. Central and South America Ophiopogonin D Sales YoY (2020-2031) & (kg)
Figure 73. Central and South America Ophiopogonin D Revenue YoY (2020-2031) & (US$ Million)
Figure 74. Central and South America Top 5 Manufacturers Ophiopogonin D Sales Revenue (US$ Million) in 2024
Figure 75. Central and South America Ophiopogonin D Sales Volume (kg) by Type (2021-2031)
Figure 76. Central and South America Ophiopogonin D Sales Revenue (US$ Million) by Type (2020-2031)
Figure 77. Central and South America Ophiopogonin D Sales Volume (kg) by Application (2020-2031)
Figure 78. Central and South America Ophiopogonin D Sales Revenue (US$ Million) by Application (2020-2031)
Figure 79. Brazil Ophiopogonin D Revenue (2020-2025) & (US$ Million)
Figure 80. Argentina Ophiopogonin D Revenue (2020-2025) & (US$ Million)
Figure 81. Middle East, and Africa Ophiopogonin D Sales YoY (2020-2031) & (kg)
Figure 82. Middle East and Africa Ophiopogonin D Revenue YoY (2020-2031) & (US$ Million)
Figure 83. Middle East and Africa Top 5 Manufacturers Ophiopogonin D Sales Revenue (US$ Million) in 2024
Figure 84. Middle East and Africa Ophiopogonin D Sales Volume (kg) by Type (2021-2031)
Figure 85. South America Ophiopogonin D Sales Revenue (US$ Million) by Type (2020-2031)
Figure 86. Middle East and Africa Ophiopogonin D Sales Volume (kg) by Application (2020-2031)
Figure 87. Middle East and Africa Ophiopogonin D Sales Revenue (US$ Million) by Application (2020-2031)
Figure 88. GCC Countries Ophiopogonin D Revenue (2020-2025) & (US$ Million)
Figure 89. Turkey Ophiopogonin D Revenue (2020-2025) & (US$ Million)
Figure 90. Egypt Ophiopogonin D Revenue (2020-2025) & (US$ Million)
Figure 91. South Africa Ophiopogonin D Revenue (2020-2025) & (US$ Million)
Figure 92. Ophiopogonin D Industry Chain Mapping
Figure 93. Regional Ophiopogonin D Manufacturing Base Distribution (%)
Figure 94. Ophiopogonin D Production Process
Figure 95. Regional Ophiopogonin D Production Cost Structure
Figure 96. Channels of Distribution (Direct Vs Distribution)
Figure 97. Bottom-up and Top-down Approaches for This Report
Figure 98. Data Triangulation
Figure 99. Key Executives Interviewed
